René Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte, Brazil.
Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Front Cell Infect Microbiol. 2021 Apr 30;11:653670. doi: 10.3389/fcimb.2021.653670. eCollection 2021.
Neglected Tropical Diseases include a broad range of pathogens, hosts, and vectors, which represent evolving complex systems. Leishmaniasis, caused by different species and transmitted to humans by sandflies, are among such diseases. and other Trypanosomatidae display some peculiar features, which make them a complex system to study. Leishmaniasis chemotherapy is limited due to high toxicity of available drugs, long-term treatment protocols, and occurrence of drug resistant parasite strains. Systems biology studies the interactions and behavior of complex biological processes and may improve knowledge of drug resistance. System-level studies to understand biology have been challenging mainly because of its unusual molecular features. Networks integrating the biochemical and biological pathways involved in drug resistance have been reported in literature. Antioxidant defense enzymes have been identified as potential drug targets against leishmaniasis. These and other biomarkers might be studied from the perspective of systems biology and systems parasitology opening new frontiers for drug development and treatment of leishmaniasis and other diseases. Our main goals include: 1) Summarize current advances in research focused on chemotherapy and drug resistance. 2) Share our viewpoint on the application of systems biology to studies. 3) Provide insights and directions for future investigation.
被忽视的热带病包括广泛的病原体、宿主和媒介,它们代表了不断进化的复杂系统。由不同物种引起、通过沙蝇传播给人类的利什曼病就是此类疾病之一。其他克氏锥虫科寄生虫具有一些特殊的特征,使它们成为一个复杂的研究系统。由于现有药物毒性高、长期治疗方案以及耐药寄生虫株的出现,利什曼病的化学疗法受到限制。系统生物学研究复杂生物过程的相互作用和行为,可能会提高对药物耐药性的认识。系统水平的研究旨在理解生物学,但由于其不寻常的分子特征,一直具有挑战性。文献中已经报道了整合涉及药物耐药性的生化和生物学途径的网络。抗氧化防御酶已被确定为抗利什曼病的潜在药物靶点。这些和其他生物标志物可能会从系统生物学和系统寄生虫学的角度进行研究,为开发药物和治疗利什曼病和其他疾病开辟新的前沿。我们的主要目标包括:1)总结目前在以化疗和药物耐药性为重点的研究方面的进展。2)分享我们对系统生物学在研究中的应用的观点。3)为未来的研究提供见解和方向。
Front Cell Infect Microbiol. 2021
Parassitologia. 1991-12
Trends Parasitol. 2020-7-23
Bioeng Bugs. 2011
Expert Rev Anti Infect Ther. 2014-8
Front Cell Infect Microbiol. 2021
Adv Parasitol. 2016
Future Microbiol. 2022-1
Front Cell Infect Microbiol. 2022
Parasit Vectors. 2020-11-30
Eur Biophys J. 2019-7
Mem Inst Oswaldo Cruz. 2018-11-14
BMC Bioinformatics. 2018-3-6
J Mol Cell Biol. 2018-4-1
Drug Des Devel Ther. 2017-12-22